Effects of CXCL10 on Dendritic Cell and CD4+T-Cell Functions duringLeishmania amazonensisInfection
- 1 January 2008
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (1), 161-169
- https://doi.org/10.1128/iai.00825-07
Abstract
Leishmania amazonensiscan cause progressive disease in most inbred strains of mice. We have previously reported that treatment with CXCL10 activates macrophage (MΦ) effector function(s) in parasite killing and significantly delays lesion development in susceptible C57BL/6 mice via enhanced gamma interferon (IFN-γ) and interleukin 12 (IL-12) secretion; however, the mechanism underlying this enhanced immunity againstL. amazonensisinfection remains largely unresolved. In this study, we utilized stationary promastigotes to infect bone marrow-derived dendritic cells (DCs) of C57BL/6 mice and assessed the activation of DC subsets and the capacity of these DC subsets to prime CD4+T cells in vitro. We found that CXCL10 induced IL-12 p40 production but reduced IL-10 production in uninfected DCs. YetL. amazonensis-infected DCs produced elevated levels of IL-10 despite CXCL10 treatment. Elimination of endogenous IL-10 led to increased IL-12 p40 production in DCs as well as increased proliferation and IFN-γ production by in vitro-primed CD4+T cells. In addition, CXCL10-treated CD4+T cells became more responsive to IL-12 via increased expression of the IL-12 receptor β2chain and produced elevated levels of IFN-γ. This report indicates the utility of CXCL10 in generating a Th1-favored, proinflammatory response, which is a prerequisite for controllingLeishmaniainfection.Keywords
This publication has 47 references indexed in Scilit:
- Role of Interleukin-1β in Activating the CD11chighCD45RB−Dendritic Cell Subset and PrimingLeishmania amazonensis- Specific CD4+T Cells In Vitro and In VivoInfection and Immunity, 2007
- CXCL10/Gamma Interferon-Inducible Protein 10-Mediated Protection againstLeishmania amazonensisInfection in MiceInfection and Immunity, 2006
- CXCR3 is required for migration to dermal inflammation by normal andin vivo activated T cells: differential requirements by CD4 and CD8 memory subsetsEuropean Journal of Immunology, 2005
- Leishmania majorModulates Chemokine and Chemokine Receptor Expression by Dendritic Cells and Affects Their Migratory CapacityInfection and Immunity, 2005
- CXCR3–/– mice mount an efficient Th1 response but fail to control Leishmania major infectionEuropean Journal of Immunology, 2005
- Allergic humans are hypo‐responsive to CXCR3 chemokines in a Th1 immunity‐promoting loopThe FASEB Journal, 2003
- Interleukin 1α Promotes Th1 Differentiation and Inhibits Disease Progression in Leishmania major–susceptible BALB/c MiceThe Journal of Experimental Medicine, 2003
- The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile CureThe Journal of Experimental Medicine, 2001
- Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent mannerEuropean Journal of Immunology, 1999
- T-lymphocytes in experimentalLeishmania amazonensis infection: comparison between immunized and naive BALB/c miceZeitschrift für Parasitenkunde, 1992